| Overall N = 57 |
Group A Mild/moderate N = 36 |
Group B Moder./severe N = 21 |
Group C Improved N = 41 |
Group D Not improved N = 16 |
|
|---|---|---|---|---|---|
| General characteristics | |||||
| Gender males | 28 (49 %) | 20 (56 %) | 8 (38 %) | 23 (56 %) | 5 (31 % ) |
| Age (mean ±SD) | 69.4 ±13.8 | 69.8 ±12.7 | 68.8 ±15.9 | 67.5 ±15.0 | 74.4 ±8.9 |
| BMI>30 | 8 (13 %) | 8 (13 %) | 0 | 7 (17 %) | 1 (5 %) |
| Smoking | 0 | 0 | 0 | 0 | 0 |
| Clinical characteristics | |||||
| Hypertension | 35 (61 %) | 21 (58 %) | 14 (66 %) | 24 (58 %) | 11 (68 %) |
| Dislipidemia | 5 (8 %) | 4 (10 %) | 1 (5 %) | 5 (12 %) | 0 |
| Atrial fibrillation | 5 (8.3%) | 4 (10 %) | 1 (5 %) | 4 (10 %) | 1 (5 %) |
| Previous stroke/TIA | 3 (5%) | 3 (7 %) | 0 | 3 (7 %) | 0 |
| Diabetes | 14 (23 %) | 12 (30 %) | 2 (10 %) | 11 (27 %) | 3 (16 %) |
| Stroke characteristics | |||||
| Basal NIHSS (mean ±SD) | 10.5 ±5.3 | 7.0 ±1.6 | 16.4 ±4.0 | 9.5 ±4.6 | 13.3 ±6.2 |
| OCSP classification (vascular territory) | |||||
| TACI | 16 (28 %) | 8 (19 %) | 8 (50 %) | ||
| LACI | 20 (35 %) | 15 (37 5) | 5 (31 %) | ||
| PACI | 18 (32 %) | 15 (37 %) | 3 (18 %) | ||
| POCI | 3 (5 %) | 3 (7 %) | 0 | ||
| TOAST classification (etiopathogenetic subtypes) | |||||
| Large vessels | 15 (26 %) | ||||
| Cardioembolic | 9 (16 %) | ||||
| Small vessels | 14 (25 %) | ||||
| Undetermined | 19 (33 %) | ||||
| Other causes | 0 | ||||